Blockade of bovine PD-1 increases T cell function and inhibits bovine leukemia virus expression in B cells in vitro

scientific article published on 22 July 2013

Blockade of bovine PD-1 increases T cell function and inhibits bovine leukemia virus expression in B cells in vitro is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1041298174
P356DOI10.1186/1297-9716-44-59
P932PMC publication ID3726328
P698PubMed publication ID23876077
P5875ResearchGate publication ID251233720

P50authorRyoyo IkebuchiQ84977791
P2093author name stringKazumasa Yokoyama
Chie Nakajima
Yasuhiko Suzuki
Kazuhiko Ohashi
Satoru Konnai
Shiro Murata
Tomohiro Okagawa
P2860cites workHost soluble factors that regulate the synthesis of the major core protein of the bovine leukemia virus (BLV) in a naturally infected neoplastic B-cell lineQ39037937
Molecular characterization of immunoinhibitory factors PD-1/PD-L1 in chickens infected with Marek's disease virusQ39345223
Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptorsQ40738490
Molecular cloning and expression analysis of bovine programmed death-1.Q43864810
Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individualsQ45382246
Induction of expression of bovine leukemia virus (BLV) in blood taken from BLV-infected cows without removal of plasmaQ45437673
Expression of bovine leukemia virus genome is blocked by a nonimmunoglobulin protein in plasma from infected cattleQ45800791
Nomenclature and characterization of leukocyte differentiation antigens in ruminantsQ46847108
Cloning and identification of porcine programmed death 1.Q53333415
Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma.Q55239393
Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritisQ56901733
The effects of purified mitogenic proteins (Pa-1 and Pa-2) from pokeweed on human T and B lymphocytes in vitroQ66889525
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in humanQ21245197
Porcine PD-L1: cloning, characterization, and implications during xenotransplantationQ24305180
Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infectionQ24564396
Efficient selection for high-expression transfectants with a novel eukaryotic vectorQ27860810
PD-1 and its ligands in tolerance and immunityQ28131650
Host immune responses in the course of bovine leukemia virus infectionQ28212667
Alternative splice variants of the human PD-1 geneQ28273137
Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytesQ28282689
Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative reviewQ28299847
Cutting edge: A monoclonal antibody specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse modelsQ28592282
Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cellsQ28754733
The immunobiology of cancer immunosurveillance and immunoeditingQ29616246
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlatesQ29620051
Feline programmed death and its ligand: characterization and changes with feline immunodeficiency virus infectionQ30157046
Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancerQ33842859
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impairedQ34080914
Programmed death-1 and its ligand are novel immunotolerant molecules expressed on leukemic B cells in chronic lymphocytic leukemiaQ34245048
Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunityQ34554995
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunctionQ34570127
Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergyQ34575119
Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignanciesQ34592058
PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients.Q34597843
Enhancing SIV-specific immunity in vivo by PD-1 blockadeQ34601856
PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccinationQ34602682
On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infectionQ35010742
Peripheral blood B-cell death compensates for excessive proliferation in lymphoid tissues and maintains homeostasis in bovine leukemia virus-infected sheepQ35101368
Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade.Q35364931
Progression to persistent lymphocytosis and tumor development in bovine leukemia virus (BLV)-infected cattle correlates with impaired proliferation of CD4+ T cells in response to gag- and env-encoded BLV proteinsQ35871823
Presence of suppressor HIV-specific CD8+ T cells is associated with increased PD-1 expression on effector CD8+ T cellsQ36666548
Transcriptional control of the bovine leukemia virus genome: role and characterization of a non-immunoglobulin plasma protein from bovine leukemia virus-infected cattleQ36914668
Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infectionQ37157206
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.Q37256978
Gene activation therapy: from the BLV model to HAM/TSP patientsQ37502152
P407language of work or nameEnglishQ1860
P921main subjectleukemiaQ29496
bovine leukemia virusQ895365
bovine leukemiaQ11570209
cell functionQ95674809
P304page(s)59
P577publication date2013-07-22
P1433published inVeterinary ResearchQ15761008
P1476titleBlockade of bovine PD-1 increases T cell function and inhibits bovine leukemia virus expression in B cells in vitro
P478volume44

Reverse relations

cites work (P2860)
Q38617885(89)Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer.
Q41488571A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma
Q40150431Anti-Bovine Programmed Death-1 Rat-Bovine Chimeric Antibody for Immunotherapy of Bovine Leukemia Virus Infection in Cattle.
Q90114979Approaches to overcome flow cytometry limitations in the analysis of cells from veterinary relevant species
Q92576846Association between bovine leukemia virus proviral load and severity of clinical mastitis
Q36411023Bovine Immunoinhibitory Receptors Contribute to Suppression of Mycobacterium avium subsp. paratuberculosis-Specific T-Cell Responses
Q38638547Bovine leukemia virus reduces anti-viral cytokine activities and NK cytotoxicity by inducing TGF-β secretion from regulatory T cells
Q39313794Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease.
Q39588896Cooperation of PD-1 and LAG-3 Contributes to T-Cell Exhaustion in Anaplasma marginale-Infected Cattle
Q55347066Cooperation of PD-1 and LAG-3 in the exhaustion of CD4+ and CD8+ T cells during bovine leukemia virus infection.
Q40778980Direct polymerase chain reaction from blood and tissue samples for rapid diagnosis of bovine leukemia virus infection.
Q34979190Effects of bovine leukemia virus infection on milk neutrophil function and the milk lymphocyte profile
Q35184928Expression of PD-L1 on canine tumor cells and enhancement of IFN-γ production from tumor-infiltrating cells by PD-L1 blockade
Q42217541Identification and characterization of bovine programmed death-ligand 2.
Q33605673In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) rat-bovine chimeric antibody against bovine leukemia virus infection
Q40198651Increase of cells expressing PD-1 and PD-L1 and enhancement of IFN-γ production via PD-1/PD-L1 blockade in bovine mycoplasmosis.
Q51750565Influence of PD-L1 cross-linking on cell death in PD-L1-expressing cell lines and bovine lymphocytes.
Q47195414Mycoplasma bovis induced inhibition of bovine PBMC proliferation is ameliorated after blocking the immune-inhibitory programmed death-1 (PD-1) receptor.
Q58579943PD-1 blockade inhibits lymphocyte apoptosis and restores proliferation and anti-viral immune functions of lymphocyte after CP and NCP BVDV infection in vitro
Q91636348PD-1-Mediated PI3K/Akt/mTOR, Caspase 9/Caspase 3 and ERK Pathways Are Involved in Regulating the Apoptosis and Proliferation of CD4+ and CD8+ T Cells During BVDV Infection in vitro
Q52684416Prostaglandin E2 Induction Suppresses the Th1 Immune Responses in Cattle with Johne's Disease.
Q92320686Prostaglandin E2-Induced Immune Exhaustion and Enhancement of Antiviral Effects by Anti-PD-L1 Antibody Combined with COX-2 Inhibitor in Bovine Leukemia Virus Infection
Q41628406The Pekin duck programmed death-ligand 1: cDNA cloning, genomic structure, molecular characterization and mRNA expression analysis
Q90603564The Possible Role of PD-1 Protein in Ganoderma lucidum-Mediated Immunomodulation and Cancer Treatment
Q90182066Upregulation of PD-L1 Expression by Prostaglandin E2 and the Enhancement of IFN-γ by Anti-PD-L1 Antibody Combined With a COX-2 Inhibitor in Mycoplasma bovis Infection

Search more.